166 related articles for article (PubMed ID: 29873834)
1. Characterization of cyclic Cushing's disease using late night salivary cortisol testing.
Jahandideh D; Swearingen B; Nachtigall LB; Klibanski A; Biller BMK; Tritos NA
Clin Endocrinol (Oxf); 2018 Sep; 89(3):336-345. PubMed ID: 29873834
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of Late-Night Salivary Cortisol in Evaluating Postoperative Remission and Recurrence in Cushing's Disease.
Amlashi FG; Swearingen B; Faje AT; Nachtigall LB; Miller KK; Klibanski A; Biller BM; Tritos NA
J Clin Endocrinol Metab; 2015 Oct; 100(10):3770-7. PubMed ID: 26196950
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing's disease following pituitary surgery.
Danet-Lamasou M; Asselineau J; Perez P; Vivot A; Nunes ML; Loiseau H; San-Galli F; Cherifi-Gatta B; Corcuff JB; Tabarin A
Clin Endocrinol (Oxf); 2015 Feb; 82(2):260-6. PubMed ID: 24975391
[TBL] [Abstract][Full Text] [Related]
4. Salivary cortisol is a useful tool to assess the early response to pasireotide in patients with Cushing's disease.
Trementino L; Cardinaletti M; Concettoni C; Marcelli G; Polenta B; Spinello M; Boscaro M; Arnaldi G
Pituitary; 2015 Feb; 18(1):60-7. PubMed ID: 24482099
[TBL] [Abstract][Full Text] [Related]
5. Late-night salivary cortisol may be valuable for assessing treatment response in patients with Cushing's disease: 12-month, Phase III pasireotide study.
Findling JW; Fleseriu M; Newell-Price J; Petersenn S; Pivonello R; Kandra A; Pedroncelli AM; Biller BM
Endocrine; 2016 Nov; 54(2):516-523. PubMed ID: 27209465
[TBL] [Abstract][Full Text] [Related]
6. Differentiating between Cushing's disease and pseudo-Cushing's syndrome: comparison of four tests.
Alwani RA; Schmit Jongbloed LW; de Jong FH; van der Lely AJ; de Herder WW; Feelders RA
Eur J Endocrinol; 2014 Apr; 170(4):477-86. PubMed ID: 24394725
[TBL] [Abstract][Full Text] [Related]
7. Specificity of late-night salivary cortisol measured by automated electrochemiluminescence immunoassay for Cushing's disease in an obese population.
Aberle J; Schulze Zur Wiesch C; Flitsch J; Veigel J; Schön G; Jung R; Reining F; Lautenbach A; Rotermund R; Riedel N
J Endocrinol Invest; 2018 Nov; 41(11):1325-1331. PubMed ID: 29550934
[TBL] [Abstract][Full Text] [Related]
8. POSTSURGICAL RECURRENT CUSHING DISEASE: CLINICAL BENEFIT OF EARLY INTERVENTION IN PATIENTS WITH NORMAL URINARY FREE CORTISOL.
Carroll TB; Javorsky BR; Findling JW
Endocr Pract; 2016 Oct; 22(10):1216-1223. PubMed ID: 27409817
[TBL] [Abstract][Full Text] [Related]
9. Use of late-night salivary cortisol to monitor response to medical treatment in Cushing's disease.
Newell-Price J; Pivonello R; Tabarin A; Fleseriu M; Witek P; Gadelha MR; Petersenn S; Tauchmanova L; Ravichandran S; Gupta P; Lacroix A; Biller BMK
Eur J Endocrinol; 2020 Feb; 182(2):207-217. PubMed ID: 31804965
[TBL] [Abstract][Full Text] [Related]
10. Dynamics of postoperative serum cortisol after transsphenoidal surgery for Cushing's disease: implications for immediate reoperation and remission.
Mayberg M; Reintjes S; Patel A; Moloney K; Mercado J; Carlson A; Scanlan J; Broyles F
J Neurosurg; 2018 Nov; 129(5):1268-1277. PubMed ID: 29271716
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Pitfalls in Cushing Disease: Surgical Remission Rates, Test Thresholds, and Lessons Learned in 105 Patients.
Mallari RJ; Thakur JD; Barkhoudarian G; Eisenberg A; Rodriguez A; Rettinger S; Cohan P; Nieman L; Kelly DF
J Clin Endocrinol Metab; 2022 Jan; 107(1):205-218. PubMed ID: 34478542
[TBL] [Abstract][Full Text] [Related]
12. The 10:00-11:00 pm urine cortisol/creatinine ratio. An alternative to late-night salivary cortisol for the diagnosis of Cushing's syndrome.
Bruno OD; Rossi MA; Juárez-Allen L; Serra HA; Albiero MC
Medicina (B Aires); 2015; 75(6):373-8. PubMed ID: 26707659
[TBL] [Abstract][Full Text] [Related]
13. Concordance of the late night salivary cortisol in patients with Cushing's syndrome and elevated urine-free cortisol.
Doi SA; Clark J; Russell AW
Endocrine; 2013 Apr; 43(2):327-33. PubMed ID: 23238876
[TBL] [Abstract][Full Text] [Related]
14. Late Night Salivary Cortisol in the diagnosis of neoplastic hypercortisolism (including cyclic Cushing's syndrome).
Raff H
Pituitary; 2022 Oct; 25(5):698-700. PubMed ID: 35334030
[TBL] [Abstract][Full Text] [Related]
15. Cushing's Syndrome: Screening and Diagnosis.
Ceccato F; Boscaro M
High Blood Press Cardiovasc Prev; 2016 Sep; 23(3):209-15. PubMed ID: 27160717
[TBL] [Abstract][Full Text] [Related]
16. Performance of salivary cortisol in the diagnosis of Cushing's syndrome, adrenal incidentaloma, and adrenal insufficiency.
Ceccato F; Barbot M; Zilio M; Ferasin S; Occhi G; Daniele A; Mazzocut S; Iacobone M; Betterle C; Mantero F; Scaroni C
Eur J Endocrinol; 2013 Jul; 169(1):31-6. PubMed ID: 23610124
[TBL] [Abstract][Full Text] [Related]
17. Late-night salivary cortisol as a screening test for Cushing's syndrome.
Raff H; Raff JL; Findling JW
J Clin Endocrinol Metab; 1998 Aug; 83(8):2681-6. PubMed ID: 9709931
[TBL] [Abstract][Full Text] [Related]
18. The diagnostic value of late-night salivary cortisol for diagnosis of subclinical Cushing's syndrome.
Kuzu I; Zuhur SS; Demir N; Aktas G; Yener Ozturk F; Altuntas Y
Endokrynol Pol; 2016; 67(5):487-492. PubMed ID: 26884297
[TBL] [Abstract][Full Text] [Related]
19. Combination therapy for Cushing's disease: effectiveness of two schedules of treatment: should we start with cabergoline or ketoconazole?
Barbot M; Albiger N; Ceccato F; Zilio M; Frigo AC; Denaro L; Mantero F; Scaroni C
Pituitary; 2014 Apr; 17(2):109-17. PubMed ID: 23468128
[TBL] [Abstract][Full Text] [Related]
20. Midnight salivary cortisol determination for assessing the outcome of transsphenoidal surgery in Cushing's disease.
Carrasco CA; Coste J; Guignat L; Groussin L; Dugué MA; Gaillard S; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2008 Dec; 93(12):4728-34. PubMed ID: 18728161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
